Target intelligence / Profile preview

Nucleolar and coiled-body phosphoprotein 1 (NOLC1)

Target
NOLC1
Molecular classification
Other (nucleolar protein), RNA polymerase I regulator, Scaffold/chaperone protein
01

Overview

Nucleolar and coiled-body phosphoprotein 1 (NOLC1) is a nucleolar protein, also known as NOPP140, that serves as a scaffolding and chaperone molecule in the nucleolus and coiled bodies. It regulates ribosome biogenesis and rRNA transcription by interacting with RNA polymerase I and associated ribosomal processing enzymes. NOLC1 is critical for nucleolus organization, ribosomal RNA processing, and the maintenance of the fibrillar center and dense fibrillar component. It shuttles between the nucleolus and cytoplasm and is involved in several biological processes, including neural crest cell development and cell proliferation regulation. Overexpression or abnormal expression of NOLC1 impacts nucleolar structure and function, represses cell proliferation, and promotes cellular senescence. NOLC1 has documented disease associations in multiple cancer types, with its expression correlating with prognosis in breast cancer and playing roles in tumorigenesis, cellular aging, and, potentially, viral infection.

Other names
NOPP140KIAA0035NS5ATP13P130Srp40Nopp140140 kDa nucleolar phosphoproteinHepatitis C virus NS5A-transactivated protein 13Nucleolar 130 kDa proteinNucleolar phosphoprotein p130Nucleolar protein p130
02

Biological functions

rRNA transcription regulationRibosome biogenesisNucleolus organizationRegulation of translationRegulation of cell proliferationNeural crest cell developmentRegulation of synaptic plasticity
03

Disease associations

Cancer (e.g., breast cancer, nasopharyngeal carcinoma, hepatocellular carcinoma, prostate cancer)Aging and cellular senescenceHepatitis C virus infectionLissencephaly
04

Biomarkers

NOLC1 expression level is associated with prognosis in cancers (including breast cancer, triple-negative breast cancer)

Beyond the preview

Go deeper on Nucleolar and coiled-body phosphoprotein 1 (NOLC1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nucleolar and coiled-body phosphoprotein 1 (NOLC1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call